Loading…
Disclosed for 9 months, Jan 2026 to Sep 2026.Published as: Invesco India Midcap Fund (Mid Cap Fund - An open ended equity scheme predominantly investing in mid cap stocks)
Invesco India Midcap Fund is an active equity fund in the Mid Cap category from Invesco Mutual Fund. In September 2026 it disclosed 43 stocks worth ₹15,749 Cr, down ₹156 Cr from Aug 2026. Its largest positions were Prestige Estates Projects Limited (7.3%), Max Healthcare Institute Limited (7.2%), Meesho Ltd (5.4%); the ten largest together made up 49.1% of the portfolio, and Healthcare Services was the biggest sector at 17.4% of its equity. Cash and debt stood at 1.2%. Compared with Aug 2026 the fund entered 2 new stocks and exited 0.
Top-10 weight is higher than 91% of peers
Holds more stocks than 16% of peers
Holds more cash than 9% of peers
Every line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it.
None.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Aug 2026, the weight rose most in Industrial Products (+1.0 pts) and Capital Markets (+1.0 pts), and fell most in Banks (−1.4 pts) and Consumer Durables (−0.5 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|
| Healthcare Services | 10.8% | 10.7% | 17.5% | 17.4% |
| Retailing | 11.8% | 15.6% | 15.0% | 14.9% |
| Banks | 14.8% | 13.9% | 14.2% | 12.8% |
| Realty | 7.3% | 9.3% | 9.0% | 9.1% |
| Pharmaceuticals & Biotechnology | 9.1% | 7.1% | 7.1% | 7.1% |
| Insurance | 6.9% | 4.8% | 4.5% | 4.7% |
| Capital Markets | 6.5% | 5.1% | 3.3% | 4.3% |
| Industrial Products | 1.9% | 2.1% | 3.0% | 4.0% |
| Finance | 5.7% | 5.2% | 4.0% | 4.0% |
| Consumer Durables | 5.4% | 4.5% | 4.5% | 3.9% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 1.5% |
| 28% |
| Apr 2026 | ₹11,767 Cr | 42 | 2 | 4 | 0.1% | 0.1% | 32% |
| Mar 2026 | ₹9,895 Cr | 44 | 1 | 0 | 0.9% | 1.0% | — |
| Feb 2026 | ₹10,772 Cr | 43 | 1 | 3 | 0.7% | 0.6% | — |
| Jan 2026 | ₹10,058 Cr | 45 | 0.4% | 0.4% | — |